Methods for treating cancer by administering an anti-Ang-2 antibody
US8980268B2 · kind B2 · utility
10Cited by
15References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2013 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | May 9, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.